Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 138 INDUSTRY 35 OTHER_GOV 2 NIH 2 NETWORK 2 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 53 Colorectal Neoplasms 42 Neoplasms 37 Lung Neoplasms 22 Breast Neoplasms 15 Colonic Neoplasms 14 Colonic Polyps 13 Rare Diseases 9 Carcinoma, Non-Small-Cell Lung 9 Carcinoma, Hepatocellular 9 Ovarian Neoplasms 7 Adenoma 7 Pulmonary Disease, Chronic Obstructive 6 Neoplasm Metastasis 6 Heart Failure 6 Rectal Neoplasms 5 Motor Activity 5 Liver Neoplasms 5 Head and Neck Neoplasms 5 Fibrosis 5 Carcinoma, Squamous Cell 5 Barrett Esophagus 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Neoplasms by Site 4 Mental Disorders 4 Lymphoma 4 Lung Diseases 4 Leukemia 4 Esophageal Neoplasms 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Cachexia × Clear all

NCT01505764 2018-07-17

The Role of Ghrelin in Cancer Cachexia

VA Office of Research and Development

Phase 2 Terminated

10 enrolled 20 charts

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡